Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00580268 · ClinicalTrials.gov registry record

Bipolar Disorder in Pregnancy and the Postpartum Period: Predictors of Morbidity

A clinical trial of Bipolar Disorder and Psychiatric Morbidity, sponsored by Massachusetts General Hospital.

Completed
Registry status
118
Enrollment target
2
Study locations

NCT00580268: Completed study of Bipolar Disorder and Psychiatric Morbidity, sponsored by Massachusetts General Hospital.

NCT00580268 is a study of Bipolar Disorder and Psychiatric Morbidity that has completed, run by Massachusetts General Hospital. The registered enrollment target is 118 participants, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (64% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00580268, a study of Bipolar Disorder and Psychiatric Morbidity, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
118 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to examine risk factors for relapse of bipolar disorder during pregnancy and the postpartum period. The main goal of this study is to find the risks that may make it more likely for a woman with bipolar disorder to experience a depressive, manic, or hypomanic episode during her pregnancy and the postpartum period.

Study Locations (2)

Georgia

  • Emory University - Atlanta

Massachusetts

  • Massachusetts Geral Hospital - Boston

Trial Details

FieldValue
Enrollment Target 118 participants
Start Date 2005-08
Est. Completion 2013-07
Massachusetts General Hospital

2,032 total trials

What the finished NCT00580268 record still lists

NCT00580268 is an observational study that tracks outcomes without assigning an intervention. The registered 118 participants enrollment target is mid-sized for trials with a published cap, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (64% lower).

The record links to 3 conditions, with Bipolar Disorder appearing as the primary indexed condition, and to 0 interventions.

NCT00580268 reports a single indexed study location in Georgia, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00580268 about?

NCT00580268 is a clinical study titled "Bipolar Disorder in Pregnancy and the Postpartum Period: Predictors of Morbidity". The purpose of this study is to examine risk factors for relapse of bipolar disorder during pregnancy and the postpartum period. The main goal of this study is to find the risks that may make it more likely for a woman with bipolar disorder to experience a depressive, manic, or hypomanic episode dur...

What is the current status of trial NCT00580268?

This trial is currently completed. The enrollment target is 118 participants. The study started on 2005-08. Estimated completion is 2013-07.

What conditions does trial NCT00580268 study?

This clinical trial studies the following conditions: Bipolar Disorder, Psychiatric Morbidity, Neonatal Outcome.

Who is sponsoring clinical trial NCT00580268?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00580268 being conducted?

This trial has 2 study locations across Georgia, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bipolar Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00580268's enrollment target sits among peer trials

118 58th of 162 higher than 104 of 162 other Bipolar Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Bipolar Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03821623 · 118 participants · Phase 2

    Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults

  • NCT04040959 · 118 participants · Phase 2

    Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD

  • NCT04696029 · 118 participants · Phase 2

    DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma

  • NCT05223192 · 118 participants · NA

    The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00580268, the US trial registry maintained by the National Library of Medicine. NCT00580268 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.